Christian Bennett is a Senior Vice President at PRECISIONadvisors, part of Precision Value & Health, where he is a leader of the US arm of the Global Pricing, Market Access & Analytics practice. He brings more than 20 years of consulting experience in the biopharmaceutical industry, with a vast majority of that experience in pricing and market access (P&MA) consulting. Christian has developed market access launch strategies across an extensive number of therapeutic areas ranging from oncology, immunology, CNS, endocrinology, cardiovascular, as well as orphan disease. His P&MA expertise is broad, and he is recognized for developing highly actionable market access launch strategies, as well as particular depth in analytic-based pricing and contracting strategy development for many top-tier US brands. Prior to Precision, Christian was a Senior Leader at ZS Associates, providing biopharmaceutical clients with analytics-based market access consulting solutions and transformational business models. Christian holds a BS from The Pennsylvania State University, and an MBA (Hons) in corporate Finance

Miriam Kalnicki has nearly 20 years of experience in healthcare, consulting and client management. At Syneos Health, Miriam helps clients address complex business challenges through customized communications strategies, designed to resonate with core stakeholders. As one of the team’s leaders in value communications, Miriam is expert in issues of pricing & access, public health, safety and regulation. Miriam has worked with clients—from small-to-mid-sized biotechs to multinational pharmaceuticals—helping them effectively disclose price at FDA approval, prepare for market access challenges, undergo value framework assessments like ICER reviews and manage risk around routine price increases. Miriam’s success is derived from a deep understanding of the American healthcare system, and the goals, abilities and shortcomings of its key players. Prior to Syneos, Miriam used that understanding to deliver innovative solutions to some of the industry’s toughest challenges. At the health tech company SocialWellth, Miriam led product innovation and program development, providing solutions to hospital and payer clients. Prior to SocialWellth, Miriam worked helped launch Happtique, a prescriptive digital health and patient engagement platform built out of the New York Hospital Association Ventures arm. As a strategic consultant, Miriam focused on a market and operations strategy for consumer products, and spearheaded initiatives to change business operations based on changing consumer perceptions and purchasing habits. She spent 5 years in government relations, where her responsibilities included program management for pharmaceutical companies doing business in Latin America and the Caribbean. Miriam has a BA from Barnard College and an MBA from Georgetown University.

Marie is a biopharma professional and PhD immunologist with over 15 years of biopharmaceutical experience in complex specialty drug care. Marie currently works as Director of Outcomes Research at Takeda Pharmaceuticals. Prior to Takeda, Marie worked in national medical access roles at Sanofi Genzyme and Intercept Pharmaceuticals, helping create access with both national US payers and PBMs for 7 drug launches. Before joining the pharmaceutical industry, Marie was an associate professor at UMASS Medical School and Instructor of Medicine at Harvard Medical School. Marie received her bachelor’s degree in biochemistry at Ithaca College, her PhD from UMASS, Amherst and specialty trained in immunology as an NIH postdoctoral fellow and Instructor of medicine at Harvard Medical school/Dana Farber Cancer Institute. Marie has three teenage daughters (ages 19, 17 and 13), is a dedicated hot yogi and outdoor enthusiast and was once pulled over for speeding on a jet ski.